1. CDK 4/6 inhibitors linked with severe lung inflammation

   News item 28 September 2019 Pages: 1 - 1

2. Nitrosamine impurities in 'sartans' in Australia

   News item 28 September 2019 Pages: 2 - 2

3. Nitrosamine impurity in ranitidine

   News item 28 September 2019 Pages: 3 - 3

4. Thiamazole (methimazole) linked with pancreatitis

   News item 28 September 2019 Pages: 4 - 4

5. Adverse event signals with aflibercept or ranibizumab

   Clinical study 28 September 2019 Pages: 5 - 5

6. Antiepileptic drug prescribing during pregnancy

   Clinical study 28 September 2019 Pages: 6 - 6

7. Antipsychotic-related severe cardiovascular ADRs

   Clinical study 28 September 2019 Pages: 7 - 7

8. Donepezil-induced rhabdomyolysis

   Clinical study 28 September 2019 Pages: 8 - 8

9. Extended dosing interval reduces risk of natalizumab-related PML

   Clinical study 28 September 2019 Pages: 9 - 9

10. Fluoroquinolones: risk of aortic and mitral regurgitation

    Clinical study 28 September 2019 Pages: 10 - 10

11. Guillain-Barré syndrome following influenza vaccination

    Clinical study 28 September 2019 Pages: 11 - 11

12. Major bleeding with rivaroxaban and aspirin

    Clinical study 28 September 2019 Pages: 12 - 12

13. Abacavir/dolutegravir/lamivudine

    Case report 28 September 2019 Pages: 13 - 13

14. Abciximab

    Case report 28 September 2019 Pages: 14 - 14

15. Aciclovir/ketorolac/prednisone

    Case report 28 September 2019 Pages: 15 - 15

16. Adalimumab/infliximab

    Case report 28 September 2019 Pages: 16 - 16

17. Adalimumab/thalidomide

    Case report 28 September 2019 Pages: 17 - 17

18. Adenovirus vaccine

    Case report 28 September 2019 Pages: 18 - 18

19. Aflibercept/ranibizumab

    Case report 28 September 2019 Pages: 19 - 19

20. Alectinib/bevacizumab/crizotinib

    Case report 28 September 2019 Pages: 20 - 20

21. Alemtuzumab

    Case report 28 September 2019 Pages: 21 - 21

22. Alendronic-acid/ciclosporin/prednisolone

    Case report 28 September 2019 Pages: 22 - 22

23. Allopurinol

    Case report 28 September 2019 Pages: 23 - 23

24. Alogliptin/antineoplastics/sitagliptin

    Case report 28 September 2019 Pages: 24 - 24

25. Aminocaproic acid/ tissue plasminogen activator

    Case report 28 September 2019 Pages: 25 - 25

26. Aminophylline

    Case report 28 September 2019 Pages: 26 - 26

27. Amiodarone

    Case report 28 September 2019 Pages: 27 - 27

28. Amoxicillin/amoxicillin/clavulanic-acid

    Case report 28 September 2019 Pages: 28 - 28

29. Amoxicillin/cefixime/loperamide

    Case report 28 September 2019 Pages: 29 - 29

30. Amoxicillin/phenoxymethylpenicillin

    Case report 28 September 2019 Pages: 30 - 30

31. Amphotericin B liposomal/fluconazole

    Case report 28 September 2019 Pages: 31 - 31

32. Amphotericin-B liposomal/posaconazole

    Case report 28 September 2019 Pages: 32 - 32

33. Anaesthetics/antidepressants interaction

    Case report 28 September 2019 Pages: 33 - 33

34. Andexanet-α/heparin interaction/rivaroxaban

    Case report 28 September 2019 Pages: 34 - 34

35. Anidulafungin

    Case report 28 September 2019 Pages: 35 - 35

36. Anlotinib/gefitinib interaction

    Case report 28 September 2019 Pages: 36 - 36

37. Antibacterials

    Case report 28 September 2019 Pages: 37 - 37

38. Antibacterials/ciclosporin

    Case report 28 September 2019 Pages: 38 - 38

39. Antibacterials/immunosuppressants

    Case report 28 September 2019 Pages: 39 - 39

40. Antibacterials/posaconazole

    Case report 28 September 2019 Pages: 40 - 40

41. Anticoagulants

    Case report 28 September 2019 Pages: 41 - 41

42. Antiemetics and antineoplastics

    Case report 28 September 2019 Pages: 42 - 42

43. Antiepileptic drugs/meropenem

    Case report 28 September 2019 Pages: 43 - 44

44. Antineoplastics

    Case report 28 September 2019 Pages: 44 - 44

45. Antineoplastics

    Case report 28 September 2019 Pages: 45 - 45

46. Antineoplastics

    Case report 28 September 2019 Pages: 46 - 46

47. Antineoplastics

    Case report 28 September 2019 Pages: 47 - 47

48. Antineoplastics

    Case report 28 September 2019 Pages: 48 - 48

49. Antineoplastics

    Case report 28 September 2019 Pages: 49 - 49

50. Antineoplastics

    Case report 28 September 2019 Pages: 50 - 50